focusing on allogeneic car t-cell therapies for myeloma
Published 2 years ago • 116 plays • Length 0:57Download video MP4
Download video MP3
Similar videos
-
0:54
ucartcs1: a novel allogeneic car-t therapy for myeloma
-
1:01
the potentially curative role of car-t therapy in myeloma
-
2:49
novel strategies to optimize car-t therapy in myeloma
-
2:46
allo-715: novel allogenic car t-cell therapy in myeloma
-
1:45
car t-cells in myeloma: patients’ perspective
-
6:23
how long will i live with multiple myeloma and is there a cure?
-
4:04
the future of myeloma treatment and the possibility of cure
-
5:55
car t-cell therapy for multiple myeloma
-
2:57
strategies to optimize car-t therapy in myeloma: bringing car-t into earlier lines
-
2:01
car-t updates in myeloma
-
9:58
the management & optimization of car t-cell therapy in myeloma
-
1:30
advances in immunotherapy for multiple myeloma
-
0:50
car-t in multiple myeloma: cilta-cel & ide-cel
-
1:38
real world use of car t-cell therapy in multiple myeloma
-
2:35
latest advances in car-t for multiple myeloma: cilta-cel & new car-t platforms
-
2:20
design of a phase i trial of allogeneic anti-cd123 car t-cells in r/r aml
-
4:04
overcoming challenges in car t-cell therapy for multiple myeloma
-
3:27
car-t cells in myeloma
-
1:22
the potential use of car-t therapy following autologous transplantation in multiple myeloma
-
3:03
the future of car-t therapy for multiple myeloma
-
1:45
evaluating nivolumab-based therapy to restore t-cell fitness in patients with r/r multiple myeloma
-
4:14
challenges with the real-world use of car-t therapy in multiple myeloma